• <output id="w98cd"></output>
    <track id="w98cd"></track>

        1. COMPANY PROFILE

          公司簡介

          Suzhou kunpeng biotechnology co., LTD., founded in February 2013, is a high-tech enterprise located in suzhou. The company takes "providing drugs, technologies and services for human disease control" as its mission and devotes itself to the r&d, production and sales of human drugs.In the field of diabetes treatment drugs, the company has established a product chain including recombinant human insulin, insulin glargine, insulin mendong, lilaru peptide and other drugs by using the unique platform of "protein fixed-point modification technology" and subversive process engineering technology development. At the same time, many new drugs such as new long-acting insulin and glp-1 analogues are also being actively promoted.The company has completed preliminary pre-clinical research in the field of osteoporosis Details>>

          獨有的“蛋白定點修飾技術”

          Us r&d base


          It has established a joint research and development center in cooperation with Texas A&M and signed an agreement on personnel training and technical exchange

          Details

          Ningbo r&d base


          Ningbo research and development center jointly established with the Yangtze river delta research institute of tsinghua university.

          Details

          Suzhou r&d base


          Kunshan small nucleic acid base has built a biomedical entrepreneurship service platform, including analysis and testing platform, pilot plant platform, CRO professional service platform and medical database.

          Details

          PRODUCT CENTER

          產品中心

          NEWS CENTER

          新聞中心
          天堂va视频一区二区

        2. <output id="w98cd"></output>
          <track id="w98cd"></track>